Research Tracker›Biomarker Atlas›Lyme Disease›Anti-Bb IgG (synovial PCR)

Anti-Bb IgG (synovial PCR) in Lyme Disease

Anti-Bb IgG (synovial PCR), also described as Lyme arthritis molecular, belongs to the molecular group of Lyme Disease (Lyme borreliosis, Borrelia burgdorferi infection) markers, but reports against Non-Lyme joint fluid point in different directions. Symptom domains tied to this marker in the source include persistent Lyme arthritis. The evidence summarised here comes from Lantos et al. 2021 and reflects averages across cohorts rather than any single patient's result.

↕ InconsistentMolecular

Summary

Direction in Lyme Disease↕ Inconsistent — reported as both higher and lower across studies, with no consistent direction
CategoryMolecular
Also described asLyme arthritis molecular
Compared againstNon-Lyme joint fluid
Associated symptomsPersistent Lyme arthritis
Test typeClinical or physiological test
SourceLantos et al. 2021 — doi:10.1016/j.idc.2021.05.001
Condition atlasLyme Disease Biomarker Atlas

Related Molecular markers in Lyme Disease

Full list: Lyme Disease Biomarker Atlas.

Frequently asked questions

Is Anti-Bb IgG (synovial PCR) high or low in Lyme Disease?

Mixed. Some studies report higher and others lower Anti-Bb IgG (synovial PCR) in Lyme Disease compared with Non-Lyme joint fluid, so no single direction is established. Source: Lantos et al. 2021.

What symptoms is Anti-Bb IgG (synovial PCR) associated with in Lyme Disease?

The cited literature associates this marker with Persistent Lyme arthritis. These are population-level associations and do not mean the marker causes the symptoms.

Which test measures Anti-Bb IgG (synovial PCR)?

It is measured as a clinical or physiological test. Many of the cited studies used research-grade assays, so clinical availability may vary.

Is one abnormal Anti-Bb IgG (synovial PCR) result diagnostic of Lyme Disease?

No. No single biomarker is diagnostic of Lyme Disease. Anti-Bb IgG (synovial PCR) findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Cite this page

Open Source Medicine Foundation. (2026). Anti-Bb IgG (synovial PCR) in Lyme Disease: direction, evidence and what it means. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/lyme/anti-bb-igg-synovial-pcr.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-06-29 · Page generated from lyme.json · Browse: Lyme Disease atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.